Histone deacetylase inhibitor OBP‑801 and amrubicin synergistically inhibit the growth of squamous cell lung carcinoma by inducing mitochondrial ASK1‑dependent apoptosis-Reference-Cited by-同舟云学术

Histone deacetylase inhibitor OBP‑801 and amrubicin synergistically inhibit the growth of squamous cell lung carcinoma by inducing mitochondrial ASK1‑dependent apoptosis

Published:2020-01-24 Issue: Volume: Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Chihara Yusuke¹,Iizumi Yosuke¹,Horinaka Mano¹,Watanabe Motoki¹,Goi Wakana¹,Morita Mie¹,Nishimoto Emi¹,Sowa Yoshihiro¹,Yamada Tadaaki²,Takayama Koichi²,Sakai Toshiyuki¹

Affiliation:

1. Department of Molecular‑Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602‑8566, Japan

2. Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602‑8566, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of ASK1 activators in cancer treatment: Current insights and future directions;Biomedicine & Pharmacotherapy;2024-09

2. Dissecting the pleiotropic roles of reactive oxygen species (ROS) in lung cancer: From carcinogenesis toward therapy;Medicinal Research Reviews;2024-01-29

3. Titanium Dioxide Nanoparticles Exacerbate Allergic Airway Inflammation via TXNIP Upregulation in a Mouse Model of Asthma;International Journal of Molecular Sciences;2021-09-14

4. Microbiome dysbiosis and epigenetic modulations in lung cancer: From pathogenesis to therapy;Seminars in Cancer Biology;2021-07